Pre-order Enquiry
Request Free Sample
2020-2025 Global Advanced Parenteral Drug Delivery Market Report - Production and Consumption Professional Analysis (Impact of COVID-19)
SKU ID : Maia-16806705 | Publishing Date : 13-Nov-2020 | No. of pages : 129
Parenteral Drug Delivery. "Parenteral" dosing means the administration of therapeutics by intravenous, subcutaneous, intradermal or intramuscular routes. The key factors that are necessities for parenteral formulations are isotonicity, biocompatibility with physiological fluids and tissues, and solubility of the drug in physiological fluids.
This report elaborates the market size, market characteristics, and market growth of the Advanced Parenteral Drug Delivery industry, and breaks down according to the type, application, and consumption area of Advanced Parenteral Drug Delivery. The report also conducted a PESTEL analysis of the industry to study the main influencing factors and entry barriers of the industry.
In Chapter 3.4 of the report, the impact of the COVID-19 outbreak on the industry was fully assessed. Fully risk assessment and industry recommendations were made for Advanced Parenteral Drug Delivery in a special period. This chapter also compares the markets of Pre COVID-19 and Post COVID-19.
In addition, chapters 8-12 consider the impact of COVID-19 on the regional economy.
Key players in the global Advanced Parenteral Drug Delivery market covered in Chapter 13:
AptarGroup
Abbott Laboratories
GlaxoSmithKline
Hoffmann-La Roche
Baxter
AstraZeneca
Dickinson
Amgen
Novartis
Boston Scientific
Pfizer
Bristol-Myers Squibb
Becton
In Chapter 6, on the basis of types, the Advanced Parenteral Drug Delivery market from 2015 to 2025 is primarily split into:
Prefillable Syringes
Injectors Cartridges
Hypodermic Syringes
IV Catheters
Other Parenteral Delivery Devices
In Chapter 7, on the basis of applications, the Advanced Parenteral Drug Delivery market from 2015 to 2025 covers:
Central Nervous System Agents
Respiratory Agents
Hormones & Related Agents
Gastrointestinal Agents
Cardiovascular Agents
Anti-Infective Agents
Nutritional Agents
Genito-Urinary Agents
Geographically, the detailed analysis of production, trade of the following countries is covered in Chapter 4.2, 5:
United States
Europe
China
Japan
India
Geographically, the detailed analysis of consumption, revenue, market share and growth rate of the following regions are covered in Chapter 8, 9, 10, 11, 12:
North America (Covered in Chapter 8)
United States
Canada
Mexico
Europe (Covered in Chapter 9)
Germany
UK
France
Italy
Spain
Others
Asia-Pacific (Covered in Chapter 10)
China
Japan
India
South Korea
Southeast Asia
Others
Middle East and Africa (Covered in Chapter 11)
Saudi Arabia
UAE
South Africa
Others
South America (Covered in Chapter 12)
Brazil
Others
2019
This report elaborates the market size, market characteristics, and market growth of the Advanced Parenteral Drug Delivery industry, and breaks down according to the type, application, and consumption area of Advanced Parenteral Drug Delivery. The report also conducted a PESTEL analysis of the industry to study the main influencing factors and entry barriers of the industry.
In Chapter 3.4 of the report, the impact of the COVID-19 outbreak on the industry was fully assessed. Fully risk assessment and industry recommendations were made for Advanced Parenteral Drug Delivery in a special period. This chapter also compares the markets of Pre COVID-19 and Post COVID-19.
In addition, chapters 8-12 consider the impact of COVID-19 on the regional economy.
Key players in the global Advanced Parenteral Drug Delivery market covered in Chapter 13:
AptarGroup
Abbott Laboratories
GlaxoSmithKline
Hoffmann-La Roche
Baxter
AstraZeneca
Dickinson
Amgen
Novartis
Boston Scientific
Pfizer
Bristol-Myers Squibb
Becton
In Chapter 6, on the basis of types, the Advanced Parenteral Drug Delivery market from 2015 to 2025 is primarily split into:
Prefillable Syringes
Injectors Cartridges
Hypodermic Syringes
IV Catheters
Other Parenteral Delivery Devices
In Chapter 7, on the basis of applications, the Advanced Parenteral Drug Delivery market from 2015 to 2025 covers:
Central Nervous System Agents
Respiratory Agents
Hormones & Related Agents
Gastrointestinal Agents
Cardiovascular Agents
Anti-Infective Agents
Nutritional Agents
Genito-Urinary Agents
Geographically, the detailed analysis of production, trade of the following countries is covered in Chapter 4.2, 5:
United States
Europe
China
Japan
India
Geographically, the detailed analysis of consumption, revenue, market share and growth rate of the following regions are covered in Chapter 8, 9, 10, 11, 12:
North America (Covered in Chapter 8)
United States
Canada
Mexico
Europe (Covered in Chapter 9)
Germany
UK
France
Italy
Spain
Others
Asia-Pacific (Covered in Chapter 10)
China
Japan
India
South Korea
Southeast Asia
Others
Middle East and Africa (Covered in Chapter 11)
Saudi Arabia
UAE
South Africa
Others
South America (Covered in Chapter 12)
Brazil
Others
Years considered for this report:
Historical Years:
2015-2019Base Year:
2019Estimated Year:
2020Forecast Period:
2020-2025Frequently Asked Questions
This market study covers the global and regional market with an in-depth analysis of the overall growth prospects in the market. Furthermore, it sheds light on the comprehensive competitive landscape of the global market. The report further offers a dashboard overview of leading companies encompassing their successful marketing strategies, market contribution, recent developments in both historic and present contexts.
- By product type
- By End User/Applications
- By Technology
- By Region
The report provides a detailed evaluation of the market by highlighting information on different aspects which include drivers, restraints, opportunities, and threats. This information can help stakeholders to make appropriate decisions before investing.
Request Sample
Request Discount
